Epistaxis
📧 Sign up to get email alerts when something new happens for Epistaxis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-01-26Clinical Trial Update: Microporous Polysaccharide Hemospheres Epistaxis [NA]
Emory University-sponsored clinical trial investigating microporous polysaccharide hemospheres for epistaxis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-29Clinical Trial Update: Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) [Phase 1]
This entry notes a Phase 1 clinical trial evaluating ranibizumab for recurrent nosebleeds in patients with hereditary hemorrhagic telangiect…
-
CLINICAL_TRIALS withdrawal · 2009-06-12Clinical Trial Update: Minimally Invasive Control of Epistaxis (MICE) [Phase 2, Phase 3]
The Minimally Invasive Control of Epistaxis (MICE) trial, conducted in Phase 2 and Phase 3 and sponsored by the University of Calgary, has b…